Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ascentage Pharma Group Corp. Ltd.

www.ascentagepharma.com

Latest From Ascentage Pharma Group Corp. Ltd.

BeiGene, Hengrui Among China Firms Flexing New Oncology Muscle At ASCO

In its bid to facilitate novel treatments for some of its most prevalent cancers, China is also poised to make a dent in the global oncology market through domestically originated agents, with the number of PD-1 and CAR-T therapies under clinical development already surpassing that in the US.

ASCO China

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.

Deals Commercial

Asia Executives On The Move: BeiGene, Henlius, Dainippon Sumitomo

Another busy time for executive moves in the Asia Pacific region, as Amgen China GM joins Henlius, BeiGene appoints new immuno-oncology CMO and Sumitomo Dainippon names a new digital health head. Changes also take place at Ascentage, Harbin Pharma and AdvaMed.

Appointments Asia Pacific

Asia Executives On The Move: Merck, Novo Nordisk, Ascentage

Merck China R&D head leaving after overseeing several high-profile drug approvals, while Novo Nordisk China's marketing head will lead the firm's operations in Oceania.
Appointments Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Ascentage Pharma Group Corp. Ltd.
  • Senior Management
  • Dajun Yang, MD, PhD, CEO
    Han Li, PhD, CFO
    Ming Guo, PhD, Pres. & COO
    Shaomeng Wang, PhD, CSO
    Yifan Zhai, MD, PhD, CMO
    Jeff Kmetz, CBO
  • Contact Info
  • Ascentage Pharma Group Corp. Ltd.
    Phone: 512-85557777
    218 Xinghu St., Suzhou Industrial Park
    Bldg.B7 7th Fl.
    Suzhou, 215000
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register